Merrimack Pharmaceuticals (MACK) Return on Equity (ROE) (2012 - 2024)
Merrimack Pharmaceuticals (MACK) Return on Equity (ROE) from Mar 31, 2012 to Mar 31, 2024. The TTM Merrimack Pharmaceuticals (MACK) Return on Equity (ROE) is 90.85%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Merrimack Pharmaceuticals (MACK)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2023 | -6.29% | -21.33% |
| 2022 | -8.00% | -53.67% |
| 2021 | -17.27% | -8.77% |
| 2020 | -18.93% | -81.10% |
| 2019 | -100.12% | +45.37% |
| 2018 | -68.87% | -114.08% |
| 2017 | 489.06% | +704.89% |
| 2016 | 60.76% | -24.48% |
| 2015 | 80.46% | -1.72% |
| 2014 | 81.87% | -72.98% |
| 2013 | 302.99% | -78.80% |
| 2012 | 1429.13% | N/A |